65
Views
13
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Brief Report: Practicability and safety of amphotericin B deoxycholate as continuous infusion in neutropenic patients with hematological malignancies

, , , &
Pages 1163-1167 | Received 05 Feb 2005, Published online: 03 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Iman Karimzadeh, Shadi Farsaei, Hossein Khalili & Simin Dashti-Khavidaki. (2012) Are salt loading and prolonging infusion period effective in prevention of amphotericin B-induced nephrotoxicity?. Expert Opinion on Drug Safety 11:6, pages 969-983.
Read now
Karen Moeremans & Lieven Annemans. (2006) Economic evaluation of the prevention and management of systemic fungal infections in neutropenic patients. Expert Opinion on Pharmacotherapy 7:14, pages 1931-1943.
Read now

Articles from other publishers (11)

T H Geersing, E J F Franssen, P E Spronk, H J M van Kan, M den Reijer & P H J van der Voort. (2022) Nephrotoxicity of continuous amphotericin B in critically ill patients with abdominal sepsis: a retrospective analysis with propensity score matching—authors’ response. Journal of Antimicrobial Chemotherapy 77:8, pages 2309-2311.
Crossref
T H Geersing, E J F Franssen, P E Spronk, H J M van Kan, M den Reijer & P H J van der Voort. (2022) Nephrotoxicity of continuous amphotericin B in critically ill patients with abdominal sepsis: a retrospective analysis with propensity score matching. Journal of Antimicrobial Chemotherapy 77:1, pages 246-252.
Crossref
Charulata Ramaprasad & Kenneth J. Pursell. 2014. Infectious Complications in Cancer Patients. Infectious Complications in Cancer Patients 351 370 .
Matthew E. Falagas, Drosos E. Karageorgopoulos & Giannoula S. Tansarli. (2013) Continuous versus Conventional Infusion of Amphotericin B Deoxycholate: A Meta-Analysis. PLoS ONE 8:10, pages e77075.
Crossref
Diego R. Falci, Rodrigo P. dos Santos, Fernanda Wirth & Luciano Z. Goldani. (2011) Continuous infusion of amphotericin B deoxycholate: an innovative, low-cost strategy in antifungal treatment. Mycoses 54:2, pages 91-98.
Crossref
Alexander Lepak & David Andes. (2011) Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting. Critical Care Clinics 27:1, pages 123-147.
Crossref
Rafael Zaragoza, Javier Pemán, Miguel Salavert, Amparo Solé, Isidro Jarque, Emilio Monte, Eva Romá & Emilia Cantón. 2010. Combating Fungal Infections. Combating Fungal Infections 241 272 .
C. Annaloro, C. Olivares, P. Usardi, F. Onida, A. Della Volpe, E. Tagliaferri & G. L. Deliliers. (2009) Retrospective evaluation of amphotericin B deoxycholate toxicity in a single centre series of haematopoietic stem cell transplantation recipients. Journal of Antimicrobial Chemotherapy 63:3, pages 625-626.
Crossref
Ronak Vakil & Glen S. Kwon. (2007) Effect of Cholesterol on the Release of Amphotericin B from PEG-Phospholipid Micelles. Molecular Pharmaceutics 5:1, pages 98-104.
Crossref
. (2006) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 15:2.
Crossref
. (2005) Current Awareness in Hematological Oncology. Hematological Oncology 23:3-4, pages 136-143.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.